[PDF] Top 20 Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
Has 10000 "Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group" found on our website. Below are the top 20 most common "Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group".
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
... acknowledgements The following members of the IELSG (listed in alphabetical order) contributed patients to the study: ...University of Nebraska Medical Centre, Omaha, NE, USA; ... Voir le document complet
9
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group
... Being a retrospective study, there was a large variability in the ...RT and CT were used alone or in combination, leading to a 98% of ORR with a 93% ... Voir le document complet
7
Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies
... characteristics of patients from PBL and LNH03 cohorts are provided in Table 1 ...males and 29 ...(42%) and disseminated (stage IV) in 44 (58%) ...had a low age-adjusted ... Voir le document complet
8
Gene expression-based risk score in diffuse large B-cell lymphoma.
... use large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma and displays heterogeneous clinical and molecular ...this study, ... Voir le document complet
12
Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma.
... is a nitrogen mus- tard derivate that induces interstrand crosslinks ...poisoning the transient topoisomerase II-DNA inter- mediate formed during transcription and replication, resulting in a ... Voir le document complet
3
The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.
... Methods/Design: The REFRACT-LYMA Cohort Study aims at including all patients (>18 years old) who are diagnosed with MCL in any stage of the disease and treated in specialized ... Voir le document complet
9
Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP
... was a positive prognostic factor in patients with follicular lymphoma irrespective of treatment [ 8 ...can the discrepancy between the in vitro observed changes of CD20 ... Voir le document complet
5
The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma
... Methods/Design: The REFRACT-LYMA Cohort Study aims at including all patients (>18 years old) who are diagnosed with MCL in any stage of the disease and treated in specialized ... Voir le document complet
9
An alternative way to look at diffuse large B-cell lymphoma : the impact of frequent engagement of ReIB NF-κB subunit on cell survival and patient outcome
... mammals, the NF-κB family is composed of five members, RelA (p65), RelB, cRel (Rel), NF-κB1 (p50 and its precursor p105) and NF-κB2 (p52 and its precursor p100) [ 10 ...form a ... Voir le document complet
138
Description of Two Cases of Anaplastic Large Cell Lymphoma Associated with a Breast Implant
... the risk between 1 per 3817 to 1 per 30 000 women with textured implant ...in the literature every case of BIA-ALCL and determine if similarities are observed between the different ... Voir le document complet
7
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study
... Hodgkin lymphoma (NLPHL) is a rare entity distinct from classical Hodgkin lym- phoma (cHL), both in terms of histopathological features and clinical ...presentation. The disease is ... Voir le document complet
9
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
... our study demonstrates that the outcome of low-risk patients treated for localized DLBCL can be improved by the addition of only four doses of rituximab to ...ACVBP. ... Voir le document complet
6
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment andfollow-up †
... count and LDH at 3, 6, 12, and 24 months, then only as needed for evaluation of suspicious symptoms or clinical findings in those patients suitable for further therapy [V, ...12, and 24 months ... Voir le document complet
5
Diffuse swelling of the buccal mucosa and palate as first and only manifestation of an extranodal non-Hodgkin ‘double-hit' lymphoma: report of a case
... member of a range of proteins initially described in follicular lymphomas that play a role in decreased apopto- sis), while there was only a weak positivity for ...BCL-6. The ... Voir le document complet
6
Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and role of radiotherapy and chemotherapy
... DISCUSSION Primary NHL of the nasal cavity is common in China, 1 accounting for 10% of all NHL in the current ...in the U. S. 5,20 As is the case with nasopharyngeal ... Voir le document complet
8
Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii
... effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by ...Melenotte and Didier Raoult The combination of doxycycline with ... Voir le document complet
3
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
... Genes of which expression is associated with outcome in R-CHOP patients Cox models were used to analyze the correlation between TLDA gene expression levels and progression free survival or overall ... Voir le document complet
23
Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
... Because the distinction between cHL and ALK − ALCL cells was unreliable prior to the availability of PAX5 immunostaining, CCL17-expressing ALK − ALCL cells may have been misclassified as cHL ... Voir le document complet
17
Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies
... Among the eight patients with CNS relapse, five had elevated LDH levels, two had at least two extranodal sites, and six had aaIPI of 2 or 3—all of which have been identified as risk ... Voir le document complet
10
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.
... MATERIALS AND METHODS The patients studied in the present biological analyses were a subset of the 477 patients analyzed in the CORAL study[15], which enrolled ... Voir le document complet
12
Sujets connexes